34-51-6. Reimbursement of manufacturer from decedent's estate prohibited.
If a patient dies while being treated by an investigational drug, biological product, or device, the manufacturer may not seek reimbursement for any outstanding debt related to the treatment or lack of insurance due to the treatment from the patient's or caretaker's estate.
Source: SL 2015, ch 188, ยง6.
Structure South Dakota Codified Laws
Title 34 - Public Health and Safety
Chapter 51 - Investigational Treatments
Section 34-51-1 - Definitions.
Section 34-51-2 - Eligible patient defined.
Section 34-51-3 - Written, informed consent.
Section 34-51-4 - Treatment with investigational drug, biological product, or device.
Section 34-51-5 - Treatment without compensation permitted.
Section 34-51-6 - Reimbursement of manufacturer from decedent's estate prohibited.
Section 34-51-7 - Health care provider not liable for recommendation.